Talk to Lauri Goldstein Personally on Her Cell - Call (772) 248-0544 Now!
We Are Available 24/7
Hand holding yellow and blue Zantac package up in front of red shelf

Zantac Updates: FDA Takes Drug Off Market and Lawsuits Emerge

Zantac was first recalled in October 2019. The drugmaker, Sanofi, said it issued the recall “due to inconsistencies in preliminary test results.” As we discussed in our February blog, “Why Was Zantac Recalled?”, the popular heartburn medication has been linked to N-nitrosodimethylamine (NDMA), which is a probable human carcinogen, or substance that could cause cancer.

At first, the U.S. Food and Drug Administration (FDA) did not require recalls, nor encourage consumers to stop taking Zantac and other ranitidine drugs. On April 1, 2020, however, that all changed.

The FDA’s Announcement

Earlier this month, the FDA asked Sanofi and other ranitidine manufacturers to withdraw Zantac and other drugs from the market immediately. The FDA could not assure the quality and safety of the drugs, so they sent removal letters to all manufacturers.

Additionally, the FDA formally recommended that consumers stop taking Zantac. Per FDA instructions, anyone who has Zantac in their homes should dispose of it safely and refrain from buying more. The FDA also urged those with ranitidine prescriptions to talk to their doctors and/or consider alternatives, such as:

  • Pepcid (famotidine)
  • Tagamet (cimetidine)
  • Nexium (esomeprazole)
  • Prevacid (lansoprazole)
  • Prilosec (omeprazole)

So far, the FDA has not found NDMA in the medications listed above. Zantac and other ranitidine products, on the other hand, contained up to 0.86 micrograms and 2.85 ppm of NDMA per dose, far exceeding the FDA’s daily intake limits of 0.096 micrograms and 0.32 ppm.

As an environmental contaminant found in food and water, small amounts of NDMA are relatively harmless, but larger amounts and exposure over time can have serious consequences.

Zantac Cancer Lawsuits

While the FDA made a decision to protect American consumers, some have already been affected by the high levels of NDMA in Zantac and other drugs. A Virginia woman sued Sanofi and other drugmakers for allegedly causing her esophageal cancer, and another woman in Florida has filed suit against several manufacturers for exposure to NDMA and colon cancer.

Other lawsuits have addressed the following ailments:

  • Rectal cancer
  • Stomach cancer
  • Bladder cancer
  • Liver cancer
  • Other diseases

Those affected have had to undergo intensive surgeries and chemotherapy. To account for their medical bills and pain and suffering, they have requested damages from Sanofi and other drugmakers.

If you’ve been diagnosed with cancer after taking Zantac for an extended period (1 year or more), Lauri J. Goldstein & Associates, PLLC may be able to help.

Discuss your case with us for free today by calling (866) 675-4427 or contacting our attorneys online.

We hope to help you hold dangerous drugmakers accountable and recover the compensation you deserve.